Reuters logo
3 months ago
BRIEF-FDA grants fast track designation to Xylocor Therapeutics lead candidate XC001
May 8, 2017 / 12:46 PM / 3 months ago

BRIEF-FDA grants fast track designation to Xylocor Therapeutics lead candidate XC001

1 Min Read

May 8 (Reuters) -

* FDA grants fast track designation to Xylocor Therapeutics lead candidate XC001

* An IND for XC001 is open with FDA and Xylocor intends to commence clinical trials upon funding Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below